Novocure Ltd at Wells Fargo Healthcare Conference Transcript
Hey, good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to host this session with NovoCure. With us, we have Bill Doyle, Executive Chairman; Ashley Cordova, CFO.
In terms of format, it's going to be a fireside chat. If anyone has a question they want to ask, you raise your hand, and we'll call on you. Also in the back, I see Ingrid Goldberg, Vice President of Investor Relations, and Adam Daney. So, thank you so much for being here, Bill and Ashley.
Questions & Answers
Let's just start with a few big picture questions. The macro environment has been challenging for all medical device companies. You guys have navigated it pretty well. So, I guess the question I have is, how do you see the macro environment playing out over the rest of this year? And can
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |